Chularat Hospital Management

Management criteria checks 4/4

Chularat Hospital's CEO is Jedsada Chokdamrongsuk, appointed in Nov 2023, has a tenure of 2.5 years. directly owns 0.005% of the company’s shares, worth THB690.69K. The average tenure of the management team and the board of directors is 3.7 years and 18.3 years respectively.

Key information

Jedsada Chokdamrongsuk

Chief executive officer

฿425.0k

Total compensation

CEO salary percentage	n/a
CEO tenure	2.5yrs
CEO ownership	0.005%
Management average tenure	3.7yrs
Board average tenure	18.3yrs

Recent management updates

Recent updates

CEO

Jedsada Chokdamrongsuk (66 yo)

2.5yrs

Tenure

฿425,000

Compensation

Dr. Jedsada Chokdamrongsuk is CEO & Director of Chularat Hospital Public Company Limited from November 14, 2023. He serves as Independent Chairman at Master Style Public Company Limited since 2020. He hold...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Jedsada Chokdamrongsuk	CEO & Director	2.5yrs	฿425.00k	0.0046% THB 690.7k
Wandee Pitsanuvanavech	Head of Compliance	9.3yrs	฿75.00k	no data
Suchai Laoveerawat	Deputy Medical Director & Executive Director	no data	฿440.00k	0.023% THB 3.6m
Yudthana Sanguansakdikosol	Deputy Chief Executive Officer	no data	no data	no data
Chutima Pincharean	Deputy Chief Executive Officer	no data	฿15.00k	no data
Suppachoke Rojcheewin	Chief Financial Officer	3.7yrs	no data	no data
Rasika Bangpong	Chief Accounting Manager	3.7yrs	no data	no data
Khemkulkorn Toomthong	Head of Internal Audit & Internal Audit Manager	no data	no data	no data
Sirinapha Lakhonchai	Company Secretary	less than a year	no data	no data

3.7yrs

Average Tenure

66yo

Average Age

Experienced Management: CHG's management team is considered experienced (3.7 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Jedsada Chokdamrongsuk	CEO & Director	2.5yrs	฿425.00k	0.0046% THB 690.7k
Suchai Laoveerawat	Deputy Medical Director & Executive Director	22.3yrs	฿440.00k	0.023% THB 3.6m
Manit Jeeradit	Independent Director	14.3yrs	฿660.00k	0.0018% THB 276.3k
Kriengsak Plussind	Chairman	22.3yrs	฿570.00k	8.24% THB 1.3b
Kumpol Plussind	Director	1yr	฿245.83k	2.31% THB 350.1m
Apirum Panyapol	Non-Executive Director	22.3yrs	฿450.00k	10.25% THB 1.6b
Wichit Siritattamrong	Non-Executive Director	22.3yrs	฿425.00k	0.042% THB 6.3m
Kobkul Panyapol	Non-Executive Director	22.3yrs	฿425.00k	8.04% THB 1.2b
Kannikar Plussind	Non-Executive Director	22.3yrs	฿350.00k	19.84% THB 3.0b
Somyos Yan-Ubol	Independent Director	14.3yrs	฿625.00k	no data
Pinit Kullavanijaya	Independent Director	14.3yrs	฿500.00k	no data
Santhat Sanguandikul	Independent Director	4yrs	฿570.00k	no data

18.3yrs

Average Tenure

71yo

Average Age

Experienced Board: CHG's board of directors are seasoned and experienced ( 18.3 years average tenure).

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/05/12 11:45
End of Day Share Price	2026/05/12 00:00
Earnings	2025/12/31
Annual Earnings	2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Chularat Hospital Public Company Limited is covered by 16 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Teerapol Udomvej	BofA Global Research
Kasem Prunratanamala	CGS International
Simon Leopold	CGS International

Chularat Hospital Management

Management criteria checks 4/4

Key information

Recent management updates

Chularat Hospital Public Company Limited, Annual General Meeting, Apr 25, 2025

Chularat Hospital Public Company Limited, Annual General Meeting, Apr 26, 2024

Chularat Hospital Public Company Limited Approves Appointment of the Directors of Sub-Committees

Less than half of directors are independent

Chularat Hospital Public Company Limited Appoints Wandee Pisanuvanavech as Deputy Chief Executive Officer

Chularat Hospital Public Company Limited Announces Executive Changes

Recent updates

Upcoming dividend of ฿0.05 per share

Consensus EPS estimates fall by 10%

Final dividend of ฿0.05 announced

Chularat Hospital Public Company Limited Proposes Cash Dividend for the Operating Period from January 1, 2025 to December 31, 2025, Payable on 22 May 2026

Price target decreased by 12% to ฿1.95

Now 23% overvalued

Now 21% overvalued

Third quarter 2025 earnings: EPS and revenues miss analyst expectations

Now 20% overvalued

Now 24% overvalued after recent price rise

Second quarter 2025 earnings: EPS and revenues miss analyst expectations

Chularat Hospital Public Company Limited to Report Q2, 2025 Results on Aug 15, 2025

New minor risk - Share price stability

Price target decreased by 8.4% to ฿2.48

Now 21% undervalued after recent price drop

Now 21% undervalued after recent price drop

First quarter 2025 earnings: EPS exceeds analyst expectations while revenues lag behind

Upcoming dividend of ฿0.05 per share

Chularat Hospital Public Company Limited Approves Dividend Payment for the Fiscal Year 2024, Payable on 23 May 2025

Price target decreased by 8.8% to ฿2.88

Final dividend of ฿0.05 announced

Full year 2024 earnings: EPS and revenues miss analyst expectations

Now 23% undervalued after recent price drop

Chularat Hospital Public Company Limited, Annual General Meeting, Apr 25, 2025

Now 21% overvalued

Now 22% undervalued

Third quarter 2024 earnings: EPS in line with expectations, revenues disappoint

Now 21% overvalued after recent price rise

First half dividend of ฿0.02 announced

Second quarter 2024 earnings: EPS misses analyst expectations

Chularat Hospital Public Company Limited Approves Interim Dividend for the Period from 1 January 2024 to 30 June 2024, Payable on September 13, 2024

First quarter 2024 earnings released: EPS: ฿0.024 (vs ฿0.022 in 1Q 2023)

Now 22% overvalued

Now 21% overvalued

Now 21% overvalued

Final dividend of ฿0.05 announced

Full year 2023 earnings: EPS misses analyst expectations

Chularat Hospital Public Company Limited, Annual General Meeting, Apr 26, 2024

Chularat Hospital Public Company Limited Approves Appointment of the Directors of Sub-Committees

Third quarter 2023 earnings: EPS exceeds analyst expectations

Consensus EPS estimates increase by 11%

Consensus EPS estimates fall by 11%

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Chularat Hospital Public Company Limited Approves an Interim Dividend for the Six-Month Period Ended 30 June 2023, Payable on 8 September 2023

Price target decreased by 7.2% to ฿3.85

First quarter 2023 earnings: EPS misses analyst expectations

Upcoming dividend of ฿0.075 per share at 4.4% yield

Less than half of directors are independent

Third quarter 2022 earnings: EPS and revenues miss analyst expectations

Chularat Hospital Public Company Limited Appoints Wandee Pisanuvanavech as Deputy Chief Executive Officer

Chularat Hospital Public Company Limited Announces Executive Changes

Upcoming dividend of ฿0.085 per share

Second quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Chularat Hospital Public Company Limited Approves Interim Dividend for the Period from 1 January 2022 to 30 June 2022, Payable on September 9, 2022

Chularat Hospital Public Company Limited Appoints Santhat Sanguandikul as Member of the Audit Committee

Consensus EPS estimates increase by 18%

First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Upcoming dividend of ฿0.17 per share

Less than half of directors are independent

Consensus EPS estimates increase by 27%

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Chularat Hospital Public Company Limited Proposes Interim Dividend, Payable on or Before May 20, 2022

Third quarter 2021 earnings released: EPS ฿0.14 (vs ฿0.026 in 3Q 2020)

Upcoming dividend of ฿0.03 per share

Consensus forecasts updated

Price target increased to ฿4.27

Chularat Hospital Public Company Limited (SET:CHG) acquired additional 10% stake in Ruampat Mae Sot International Company.

Consensus EPS estimates increase to ฿0.10

First quarter 2021 earnings released: EPS ฿0.023 (vs ฿0.017 in 1Q 2020)